论文部分内容阅读
目的观察血脂康治疗糖尿病合并高脂血症的疗效。方法将60例糖尿病并高脂血症病人随机分为治疗组(降血糖+血脂康)30例,对照组(常规降血糖)30例。两组均治疗15d,治疗前后检查血糖、血脂,并发症发生率。结果治疗组能降低血糖、血脂及慢性并发症,有效率93.3%,对照组有效率60.0%,治疗组疗效明显高于对照组(P<0.05)。结论血脂康能降低糖尿病并高脂血症血脂,降低糖尿病慢性并发症。
Objective To observe the therapeutic effect of Xuezhikang on diabetic patients with hyperlipidemia. Methods Sixty diabetes and hyperlipidemia patients were randomly divided into treatment group (hypoglycemic + Xuezhikang) 30 cases, control group (conventional hypoglycemic) 30 cases. Both groups were treated 15d, before and after treatment to check blood sugar, blood lipids, the incidence of complications. Results The treatment group can reduce blood sugar, blood lipids and chronic complications, the effective rate was 93.3%, the control group was 60.0%, the treatment group was significantly higher than the control group (P <0.05). Conclusion Xuezhikang can reduce diabetes and hyperlipidemia, reduce the chronic complications of diabetes.